GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease Study 2017. Lancet. 2018;392:1789–858.
Article
Google Scholar
Kazdin AE, Rabbitt SM. Novel models for delivering mental health services and reducing the burdens of mental illness. Clin Psychol Sci. 2013;1:170–91.
Article
Google Scholar
World Health Organization. The global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. 2011; December:1–6. http://www.who.int/mental_health/WHA65.4_resolution.pdf.
World Health Organization. Depression. 2021. https://www.who.int/news-room/fact-sheets/detail/depression.
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705.
Article
PubMed
PubMed Central
Google Scholar
de las Cuevas C, Peñate W, de GarcíaCecilia JM, de Leon J. Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients. Int J Clin Heal Psychol. 2018;18:133–42.
Article
Google Scholar
Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord. 2016;193:1–10.
Article
PubMed
Google Scholar
Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284–90.
Article
PubMed
PubMed Central
Google Scholar
Simon GE, Johnson E, Stewart C, Rossom RC, Beck A, Coleman KJ, et al. Does patient adherence to antidepressant medication actually vary between physicians? J Clin Psychiatry. 2018;79:7–10.
Article
Google Scholar
Garrido MM, Boockvar KS. Perceived symptom targets of antidepressants, anxiolytics, and aedatives: the search for modifiable factors that improve adherence. J Behav Heal Serv Res. 2014;41:529–38.
Article
Google Scholar
Lee M, Lee H, Kang SG, Yang J, Ahn H, Rhee M, et al. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. J Affect Disord. 2010;123:216–21.
Article
CAS
PubMed
Google Scholar
Hung CI. Factors predicting adherence to antidepressant treatment. Curr Opin Psychiatry. 2014;27:344–9.
Article
PubMed
Google Scholar
Chong WW, Aslani P, Chen TF. Effectiveness of interventions to improve antidepressant medication adherence: A systematic review. Int J Clin Pract. 2011;65:954–75.
Article
CAS
PubMed
Google Scholar
Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry. 2002;180:104–9.
Article
CAS
PubMed
Google Scholar
Vergouwen ACM, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2003;64:1415–20.
Article
PubMed
Google Scholar
Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: a protocol for a systematic review. Syst Rev. 2018;7:10.
Article
PubMed
PubMed Central
Google Scholar
Loots E, Goossens E, Vanwesemael T, Morrens M, Van Rompaey B, Dilles T. Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18:10213.
Article
PubMed
PubMed Central
Google Scholar
Allemann SS, Nieuwlaat R, van den Bemt BJF, Hersberger KE, Arnet I. Matching adherence interventions to patient determinants using the theoretical domains framework. Front Pharmacol. 2016;7:429.
Article
PubMed
PubMed Central
Google Scholar
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Version 5. The Cochrane Collaboration; 2011.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.
Google Scholar
Higgins JP, Savović E, Page MJ, Sterne JA. Revised Cochrane risk of bias tool for randomized trials (RoB 2.0). In: Chandler J, McKenzie I, Boutron I, Welch V, editors. Cochrane Methods. Cochrane Database of Systematic Review; 2016. p. (Suppl 1).
Eldridge S, Campbell M, Campbell M, Dahota A, Giraudeau B, Higgins J, et al. Revised Cochrane risk of bias tool for randomized trials (RoB 2.0) Additional considerations for cluster-randomized trials. Cochrane Methods. 2016;18.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Article
PubMed
PubMed Central
Google Scholar
Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Article
CAS
PubMed
Google Scholar
Adler DA, Bungay KM, Wilson IB, Pei Y, Supran S, Peckham E, et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004;26:199–209.
Article
PubMed
Google Scholar
Akerblad A-C, Bengtsson F, Ekselius L, von Knorring L. Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners. Int Clin Psychopharmacol. 2003;18:347–54.
Article
PubMed
Google Scholar
Desplenter F, Laekeman G, Simoens S. Differentiated information on antidepressants at hospital discharge: a hypothesis-generating study. Int J Pharm Pract. 2013;21:252–62.
Article
PubMed
Google Scholar
Gervasoni N, Legendre-Simon P, Aubry JM, Gex-Fabry M, Bertschy G, Bondolfi G. Early telephone intervention for psychiatric outpatients starting antidepressant treatment. Nord J Psychiatry. 2010;64:265–7.
Article
PubMed
Google Scholar
Hammonds T, Rickert K, Goldstein C, Gathright E, Gilmore S, Derflinger B, et al. Adherence to antidepressant medications: a randomized controlled trial of medication reminding in college students. J Am Coll Heath. 2015;63:204–8.
Article
Google Scholar
Interian A, Lewis-Fernández R, Gara MA, Escobar JI. A randomized-controlled trial of an intervention to improve antidepressant adherence among latinos with depression. Depress Anxiety. 2013;30:688–96.
Article
PubMed
Google Scholar
John AP, Singh NM, Nagarajaiah, Andrade C. Impact of an educational module in antidepressant-naive patients prescribed antidepressants for depression: Pilot, proof-of-concept, randomized controlled trial. Indian J Psychiatry. 2016;58:425–31.
Article
PubMed
PubMed Central
Google Scholar
Katon W, Russo J, Von Korff M, Lin E, Simon G, Bush T, et al. Long-term Effects of a collaborative care intervention in persistently depressed primary care patients. J Gen Intern Med. 2002;17:741–8.
Article
PubMed
PubMed Central
Google Scholar
Katon W, Rutter C, Ludman EJ, Von Korff M, Lin E, Simon G, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241–7.
Article
CAS
PubMed
Google Scholar
Katon W, Von KM, Lin E, Simon G, Walker E. Stepped collaborative care for primary care patients with persistent symptoms of depression. Arch Gen Psychiatry. 1999;56:1109–15.
Article
CAS
PubMed
Google Scholar
Katon W, Robinson P, Von KM, Lin E, Bush T, Ludman E, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924–32.
Article
CAS
PubMed
Google Scholar
Katon W. Collaborative management to achieve treatment guidelines. JAMA. 1995;273:1026.
Article
CAS
PubMed
Google Scholar
Al-Saffar N, Abdulkareem A, Abdulhakeem A, Salah A, Heba M. Depressed patients’ preferences for education about medications by pharmacists in Kuwait. Patient Educ Couns. 2008;72:94–101.
Article
PubMed
Google Scholar
Keeley RD, Burke BL, Brody D, Dimidjian S, Engel M, Emsermann C, et al. Training to use motivational interviewing techniques for depression: a cluster randomized trial. J Am Board Fam Med. 2014;27:621–36.
Article
PubMed
Google Scholar
Klang SH, Ben-Amnon Y, Cohen Y, Barak Y. Community pharmacists’ support improves antidepressant adherence in the community. Int Clin Psychopharmacol. 2015;30:316–9.
Article
PubMed
Google Scholar
Kutcher S, Leblanc J, Maclaren C, Hadrava V. A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:591–6.
Article
CAS
PubMed
Google Scholar
LeBlanc A, Herrin J, Williams MD, Inselman JW, Branda ME, Shah ND, et al. Shared decision making for antidepressants in primary care a cluster randomized trial. JAMA Intern Med. 2015;175:1761–70.
Article
PubMed
PubMed Central
Google Scholar
Lin EHB, Von Korff M, Ludman EJ, Rutter C, Bush TM, Simon GE, et al. Enhancing adherence to prevent depression relapse in primary care. Gen Hosp Psychiatry. 2003;25:303–10.
Article
PubMed
Google Scholar
Lin EHB, Simon GE, Katon WJ, Russo JE, Von Korff M, Bush TM, et al. Can enhanced acute-phase treatment of depression improve long-term outcomes? A report of randomized trials in primary care. Am J Psychiatry. 1999;156:643–5.
CAS
PubMed
Google Scholar
Mantani A, Kato T, Furukawa TA, Horikoshi M, Imai H, Hiroe T, et al. Smartphone cognitive behavioral therapy as an adjunct to pharmacotherapy for refractory depression: Randomized controlled trial. J Med Internet Res. 2017;19:1–20.
Article
Google Scholar
Meglic M, Furlan M, Kuzmanic M, Kozel D, Baraga D, Kuhar I, et al. Feasibility of an eHealth service to support collaborative depression care: results of a pilot study. J Med Internet Res. 2010;12:1–17.
Article
Google Scholar
Mundt JC, Clarke GN, Burroughs D, Brenneman DO, Griest JH. Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education. Depress Anxiety. 2001;13:1–10.
Article
CAS
PubMed
Google Scholar
Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on dothiepin. J Int Med Res. 1976;4:237–40.
Article
CAS
PubMed
Google Scholar
Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counselling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract. 2005;13:123–32.
Article
Google Scholar
Myers E, Calvert E. Information, compliance and side-effects: a study of patients on antidepressant medication. Br J Clin Pharmacol. 1984;17:21–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nwokeji ED, Bohman TM, Wallisch L, Stoner D, Christensen K, Spence RR, et al. Evaluating patient adherence to antidepressant therapy among uninsured working adults diagnosed with major depression: results of the Texas demonstration to maintain independence and employment study. Adm Policy Ment Heal Ment Heal Serv Res. 2012;39:374–82.
Article
Google Scholar
Perahia DGS, Quail D, Gandhi P, Walker DJ, Peveler RC. A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression. J Affect Disord. 2008;108:33–41.
Article
CAS
PubMed
Google Scholar
Pradeep J, Isaacs A, Shanbag D, Selvan S, Srinivasan K. Enhanced care by community health workers in improving treatment adherence to antidepressant medication in rural women with major depression. Indian J Med Res. 2003;461:236–45.
Google Scholar
Richards DA, Bower P, Chew-Graham C, Gask L, Lovell K, Cape J, et al. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial. Health Technol Assess (Rockv). 2016;20:1–192.
Article
Google Scholar
Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Pharmacist telemonitoring of antidepressant use: Effects on pharmacist-patient collaboration. J Am Pharm Assoc. 2005;45:344–53.
Article
Google Scholar
Rickles N, Svarstad B, Statz-Paynter J, Taylor L, Kobak K. Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies. J Am Pharm Assoc. 2006;46:25–32.
Article
Google Scholar
Salkovskis P, Rimes K, Stephenson D, Sacks G, Scott J. A randomized controlled trial of the use of self-help materials in addition to standard general practice treatment of depression compared to standard treatment alone. Psychol Med. 2006;36:325–33.
Article
PubMed
Google Scholar
Simon GE, Ludman EJ, Operskalski BH. Randomized trial of a telephone care management program for outpatients starting antidepressant treatment. Psychiatr Serv. 2006;57:1441–5.
Article
PubMed
Google Scholar
Simon GE, Ralston JD, Savarino J, Pabiniak C, Wentzel C, Operskalski BH. Randomized trial of depression follow-up care by online messaging. J Gen Intern Med. 2011;26:698–704.
Article
PubMed
PubMed Central
Google Scholar
Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015;15:1–9.
Article
CAS
Google Scholar
Smit A, Tiemens BG, Ormel J, Kluiter H, Jenner JA, van de Meer K, et al. Enhanced treatment for depression in primary care: First year results on compliance, self-efficacy, the use of antidepressants and contacts with the primary care physician. Prim Care Community Psychiatry. 2005;10:39–49.
Google Scholar
Vannachavee U, Seeherunwong A, Yuttatri P, Chulakadabba S. The effect of a drug adherence enhancement program on the drug adherence behaviors of patients with major depressive disorder in Thailand: a randomized clinical trial. Arch Psychiatr Nurs. 2016;30:322–8.
Article
PubMed
Google Scholar
Vergouwen AC, Burger H, Verheij TJ, Koerselman F. Improving patients’ beliefs about antidepressants in primary care. Prim Care Companion J Clin Psychiatry. 2009;11:48–52.
Article
PubMed
PubMed Central
Google Scholar
Vergouwen AC, Bakker A, Burger H, Verheij TJ, Koerselman F. A cluster randomized trial comparing two interventions to improve treatment of major depression in primary care. Psychol Med. 2005;35:25–33.
Article
PubMed
Google Scholar
Wiles N, Hollinghurst S, Mason V, Musa M, Burt V, Hyde J, et al. A randomized controlled trial of cognitive behavioural therapy as an adjunct to pharmacotherapy in primary care based patients with treatment resistant depression: a pilot study. Behav Cogn Psychother. 2008;36:21–33.
Article
Google Scholar
Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381:375–84.
Article
PubMed
Google Scholar
Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014;18:1–167.
Article
PubMed
PubMed Central
Google Scholar
Guo T, Xiang YT, Xiao L, Hu CQ, Chiu HFK, Ungvari GS, et al. Measurement-based care versus standard care for major depression: a randomized controlled trial with blind raters. Am J Psychiatry. 2015;172:1004–13.
Article
PubMed
Google Scholar
Yusuf H, Magaji MG, Maiha BB, Yakubu SI, Haruna WC, Mohammed S. Impact of pharmacist intervention on antidepressant medication adherence and disease severity in patients with major depressive disorder in fragile north-east Nigeria. J Pharm Heal Serv Res. 2021;12:410–6.
Article
Google Scholar
Marasine NR, Sankhi S, Lamichhane R. Impact of pharmacist intervention on medication adherence and patient-reported outcomes among depressed patients in a private psychiatric hospital of Nepal: a randomised controlled trial. Hosp Pharm. 2020;57(1):26–31. https://doi.org/10.1177/0018578720970465.
Article
PubMed
Google Scholar
Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-Month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord. 2002;68:317–30.
Article
PubMed
Google Scholar
Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Heal Syst Pharm. 2004;61:364–72.
Article
Google Scholar
Chang TE, Jing Y, Yeung AS, Brenneman SK, Kalsekar ID, Hebden T, et al. Depression monitoring and patientbehavior in the clinical outcomes in measurement-based treatment (COMET) Trial. Psychiatr Serv. 2014;65:1058–61.
Article
PubMed
Google Scholar
Crockett J, Taylor S, Grabham A, Stanford P. Patient outcomes following an intervention involving community pharmacists in the management of depression. Aust J Rural Health. 2006;14:263–9.
Article
PubMed
Google Scholar
De Jonghe F, Kool S, Van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord. 2001;64:217–29.
Article
PubMed
Google Scholar
Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, et al. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol. 22(5):474–80. https://doi.org/10.1097/00004714-200210000-00006.
Ekers D, Murphy R, Archer J, Ebenezer C, Kemp D, Gilbody S. Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis. J Affect Disord. 2013;149:14–22.
Article
PubMed
Google Scholar
Van den Broeck K, Remmen R, Vanmeerbeek M, Destoop M, Dom G. Collaborative care regarding major depressed patients: a review of guidelines and current practices. J Affect Disord. 2016;200:189–203.
Article
PubMed
Google Scholar
Conn VS, Ruppar TM, Enriquez M, Cooper PS, Chan KC. Healthcare provider targeted interventions to improve medication adherence: systematic review and meta-analysis. Int J Clin Pract. 2015;69(8):889–99.
Article
CAS
PubMed
Google Scholar
Farmer AJ, McSharry J, Rowbotham S, McGowan L, Ricci-Cabello I, French DP. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with type 2 diabetes: a systematic review of randomized trials. Diabet Med. 2016;33:565–79.
Article
CAS
PubMed
Google Scholar
MacDonald L, Chapman S, Syrett M, Bowskill R, Horne R. Improving medication adherence in bipolar disorder: a systematic review and meta-analysis of 30 years of intervention trials. J Affect Disord. 2016;194:202–21.
Article
PubMed
Google Scholar
Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence Apps: potential benefits to patients and providers. J Am Pharm Assoc. 2013;53:172–81.
Article
Google Scholar
Rootes-Murdy K, Glazer KL, Van Wert MJ, Mondimore FM, Zandi PP. Mobile technology for medication adherence in people with mood disorders: a systematic review. J Affect Disord. 2017;227:613–7.
Article
PubMed
Google Scholar
Cavanagh K. Geographic inequity in the availability of cognitive behavioural therapy in england and wales: a 10-year update. Behav Cogn Psychother. 2014;42:497–501.
Article
PubMed
Google Scholar
Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.
Article
PubMed
PubMed Central
Google Scholar
Keyloun KR, Hansen RN, Hepp Z, Gillard P, Thase ME, Devine EB. Adherence and persistence across antidepressant therapeutic classes: a retrospective claims analysis among insured us patients with major depressive disorder (MDD). CNS Drugs. 2017;31(5):421–32.
Article
PubMed
PubMed Central
Google Scholar
Ji N-J, Jeon S-Y, Min K-J, Ki M, Lee W-Y. The effect of initial antidepressant type on treatment adherence in outpatients with new onset depression. J Affect Disord. 2022;311:582–7.
Article
PubMed
Google Scholar